Scientist
Janssen Research and Development
Spring House, Pennsylvania
Dr. Karan Agrawal is a Scientist in the Bioanalytical Discovery and Development Sciences team within the Preclinical Sciences and Translational Safety organization at Janssen Research and Development. In this role, Karan focuses on the development and application of bioanalytical assays for the identification and measurement of biomarkers to support the assessment of target engagement, pharmacodynamics effect, and drug-drug interaction. Dr. Agrawal also supports the quantitative and qualitative assessment of drug candidates and their metabolites in the biological matrix, with a focus on novel modalities.
Prior to joining Janssen, Karan was a Staff Scientist at Covance by LabCorp in Indianapolis, Indiana, where he was responsible for bioanalytical method development and validation for small and large molecule projects. Dr. Agrawal earned a B.A. in Chemistry and Molecular Biology from Cornell University, an M.Sc. in Forensic Science from King’s College London, and a Ph.D. in Pharmacology and Toxicology from the University of California-Davis.
Disclosure information not submitted.
Wednesday, October 19, 2022
10:00 AM – 10:30 AM ET